| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | FH535 | GDSC1000 | pan-cancer | AAC | 0.078 | 0.02 |
| mRNA | LY-2183240 | CTRPv2 | pan-cancer | AAC | 0.071 | 0.02 |
| mRNA | cediranib | CTRPv2 | pan-cancer | AAC | 0.12 | 0.02 |
| mRNA | Gemcitabine | CTRPv2 | pan-cancer | AAC | 0.073 | 0.02 |
| mRNA | GDC-0941 | gCSI | pan-cancer | AAC | 0.13 | 0.03 |
| mRNA | parbendazole | CTRPv2 | pan-cancer | AAC | 0.067 | 0.03 |
| mRNA | Mitomycin-C | CTRPv2 | pan-cancer | AAC | 0.071 | 0.03 |
| mRNA | SNS-032 | CTRPv2 | pan-cancer | AAC | 0.076 | 0.03 |
| mRNA | Axitinib | CTRPv2 | pan-cancer | AAC | 0.072 | 0.03 |
| mRNA | LE-135 | CTRPv2 | pan-cancer | AAC | 0.075 | 0.03 |